Companies: 10,795·Total market cap: $144.5T
Genmab A/S

Genmab A/S

GNMSFOTCHealthcare● Active
$249.45
$-21.15(-7.82%)
Market Cap$15.3B
P/E Ratio—
52W High$352
52W Low$198.51
Overview

Genmab A/S (GNMSF) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · GNMSF · as of Feb 17, 2026

Latest filing snapshot

3,029
+347+12.94%vs prior year

Genmab A/S (GNMSF) employee data is sourced from the annual SEC 20-F filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 20-F·Period end: 2025-12-31·Full-time · Global
Total Employees
3,029
Change (1Y)
+347
Growth % (1Y)
+12.94%
Revenue / Employee
$1.27M
Net Income / Employee
$329.1K
Market Cap
$15.3B

GNMSF Employee Count

2019 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-02-173,029+347+12.94%
2025-02-122,682+478+21.69%
2024-02-142,204+544+32.77%
2023-02-221,660+448+36.96%
2022-02-161,212+431+55.19%
2021-03-29781+233+42.52%
2020-03-30548——

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Grifols, S.A.
GIKLY
Grifols, S.A.
23,833
#2
Astellas Pharma Inc.
ALPMF
Astellas Pharma Inc.
14,754
#3
Astellas Pharma Inc.
ALPMY
Astellas Pharma Inc.
14,754
#4
bioMérieux S.A.
BMXXY
bioMérieux S.A.
14,147
#5
Innovent Biologics, Inc.
IVBXF
Innovent Biologics, Inc.
5,659
#6
Orion Oyj
ORINY
Orion Oyj
3,943
#7
Genmab A/S
GNMSF
Genmab A/SYOU
3,029
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · GNMSF peer comparison

About GNMSF employees

GNMSF Employees · Headcount

Genmab A/S (GNMSF) employee data is sourced from the annual SEC 20-F filing. As of 2025, Genmab A/S had 3,029 full-time employees globally. Full-time employees only. Global consolidated headcount.

Genmab A/S employs 3,029 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.27M, reflecting the company's operational efficiency.

Genmab A/S's workforce increased by 347 (12.94%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Genmab A/S's revenue per employee of $1.27M positions it among the notable performers in the Biotechnology sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

GNMSF Employees · 5 questions

As of the latest SEC 20-F filing (2025), Genmab A/S had 3,029 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Genmab A/S employee counthow many employees does Genmab A/S haveGNMSF total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-17